A Phase I-II Study to Assess the Safety, Efficacy and Pharmacokinetic Profile of HM781-36B Combined With Paclitaxel and Trastuzumab in Patients With HER-2 Positive Advanced Gastric Cancer
Phase of Trial: Phase I/II
Latest Information Update: 25 Aug 2016
At a glance
- Drugs Poziotinib (Primary) ; Paclitaxel; Trastuzumab
- Indications Gastric cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 02 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2013 Lead trial centre amended as reported by ClinicalTrials.gov.